Trial no.:
|
PACTR201702002039148 |
Date of Approval:
|
13/02/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
dexmedetomidine levobupivavcaine |
Official scientific title |
Intraperitoneal Levobupivacaine alone or with dexmedetomidine for postoperative analgesia after laparoscopic cholecystectomy. |
Brief summary describing the background
and objectives of the trial
|
Laparoscopic cholecystectomy recently is the most commonly performed procedure for gall stones. Laparoscopic surgery has many advantages over open procedures such as lesser hemorrhage, better cosmosis, lesser postoperative pain, and shorter recovery time, leading to shorter hospital stay and less expenditure.
Pain results from stretching of the intra¿abdominal cavity, [3] peritoneal inflammation, and diaphragmatic irritation caused by residual carbon¿dioxide in the peritoneal cavity.
Many methods have been proposed to relieve post¿operative pain following laparoscopic cholecystectomy. Intraperitoneal instillation of local anesthetic agents alone or in combination with opioids, ¿¿2 agonists such as clonidine and dexmedetomidine have been found to reduce post¿operative pain following laparoscopic cholecystectomy
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
postoperative pain |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/03/2017 |
Actual trial start date |
01/03/2017 |
Anticipated date of last follow up |
01/06/2017 |
Actual Last follow-up date |
01/06/2017 |
Anticipated target sample size (number of participants) |
105 |
Actual target sample size (number of participants) |
120 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|